Search Results - (Author, Cooperation:B. H. Chong)
-
1G. J. Maghzal ; S. Winter ; B. Wurzer ; B. H. Chong ; R. Holmdahl ; R. Stocker
Nature Publishing Group (NPG)
Published 2014Staff ViewPublication Date: 2014-10-25Publisher: Nature Publishing Group (NPG)Print ISSN: 0028-0836Electronic ISSN: 1476-4687Topics: BiologyChemistry and PharmacologyMedicineNatural Sciences in GeneralPhysicsKeywords: Animals ; Granulomatous Disease, Chronic/*metabolism/*pathology ; Inflammation/*metabolism ; Kynurenine/*metabolism ; Tryptophan/*metabolismPublished by: -
2Staff View
ISSN: 1432-0584Keywords: Thrombocytopenia ; Heparin anticoagulant therapy ; ComplicationSource: Springer Online Journal Archives 1860-2000Topics: MedicineNotes: Summary Thrombocytopenia is a frequent and sometimes insidious complication of anticoagulant therapy with heparin. Two types of heparin-induced thrombocytopenia with a distinct aetiology have been recognized. Type I is characterized by a mild thrombocytopenia of early onset which requires careful monitoring but usually not the cessation of heparin therapy. The mild thrombocytopenia is probably due to the mild pro-aggregatory properties of heparin and can be more severe in the presence of other predisposing factors, e.g. sepsis. Type II heparin-induced thrombocytopenia is more severe and usually occurs after a period of 7–10 days. Heparin therapy should be ceased immediately and other anticoagulant therapy initiated. The thrombocytopenia is believed to be due to the development of a heparin-dependent antibody that causes platelet aggregation and release. The precise mechanism of heparin-dependent antibody-platelet interaction is still not entirely clear but probably involves the binding of an antibody-heparin immune complex to the platelet Fc receptor.Type of Medium: Electronic ResourceURL: -
3Staff View
ISSN: 1432-1238Source: Springer Online Journal Archives 1860-2000Topics: MedicineType of Medium: Electronic ResourceURL: